Coverage
-
February 17, 2015
Boston Scientific Corp. announced Tuesday it would pay Johnson & Johnson $600 million to settle claims that acquisition target Guidant Corp. breached a contract by scuttling a proposed $21.5 billion merger with J&J, the deal coming before a judge could rule in the case's concluded bench trial.
5 other articles on this case.
View all »